Cytodyn Inc CYDY:OTCQB

*Data is delayed | Exchange | USD
Last | 10:13 AM EDT
0.1486quote price arrow up+0.003 (+2.0604%)
Volume
27,486
52 week range
0.13 - 0.42
Loading...
  • Open0.1493
  • Day High0.1493
  • Day Low0.145
  • Prev Close0.1456
  • 52 Week High0.42
  • 52 Week High Date12/07/23
  • 52 Week Low0.13
  • 52 Week Low Date04/15/24

Key Stats

  • Market Cap147.614M
  • Shares Out993.37M
  • 10 Day Average Volume779,877.86
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-25.64

KEY STATS

  • Open0.1493
  • Day High0.1493
  • Day Low0.145
  • Prev Close0.1456
  • 52 Week High0.42
  • 52 Week High Date12/07/23
  • 52 Week Low0.13
  • 52 Week Low Date04/15/24
  • Market Cap147.614M
  • Shares Out993.37M
  • 10 Day Average Volume779,877.86
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-25.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-2.83
  • Fwd P/E (NTM)-1.24
  • EBITDA (TTM)-15.169M
  • ROE (TTM)-566.11%
  • Revenue (TTM)-
  • Gross Margin (TTM)-33,787.11%
  • Net Margin (TTM)-89,045.78%
  • Debt To Equity (MRQ)-25.27%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cytodyn Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. The Company is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Its core areas of clinical...
Tanya Urbach
Independent Chairman of the Board
Jacob Lalezari M.D.
Chief Executive Officer
Mitchell Cohen
Interim Chief Financial Officer
Tyler Blok
Executive Vice President - Legal Affairs, Joint Company Secretary
Address
1111 Main St Ste 660
Vancouver, WA
98660-2970
United States

Top Peers

SYMBOLLASTCHG%CHG
NVCT
Nuvectis Pharma Inc
6.54+0.13+2.11%
PDSB
PDS Biotechnology Corp
3.61+0.10+2.85%
BCAB
Bioatla Inc
2.76+0.05+1.85%
RZLT
Rezolute Inc
2.89-0.10-3.35%
PROK
ProKidney Corp
3.12+0.31+11.03%